SAN DIEGO—A San Diego County pharmacy chain has paid $350,000 to resolve allegations that numerous controlled substances went unaccounted for at its El Cajon storefront, it was announced May 2.
A U.S. Drug Enforcement Administration investigation found that Palm Care Pharmacy’s El Cajon location “failed to control its inventory of controlled substances, failed to maintain a complete record of controlled substances and the transactions, and sold listed chemical products (e.g., pseudoephedrine) without the necessary training and certification,” according to the U.S. Attorney’s Office.
